Evidence map›Paper›PMID 36706677›Full record

ArticleProstaglandins, leukotrienes, and essential fatty acids2023

The prohibitin complex regulates macrophage fatty acid composition, plasma membrane packing, and lipid raft-mediated inflammatory signaling.

Christine E Psaltis Matthews, Lynn A Fussner, Michael Yaeger, Jim J Aloor, Sky W Reece, Brita J Kilburg-Basnyat, Sanjay Varikuti, Bin Luo, Morgan Inks, Selin Sergin and 10 more

Open access · greenAbstract read
In one paragraph

Article in Prostaglandins, leukotrienes, and essential fatty acids, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Prohibitions in the meta-inflammatory response: a review.Frontiers in molecular biosciences · 2024
    Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 7 institutions in 1 country.

Christine E Psaltis MatthewsDepartment of Pharmacology and Toxicology, Brody School of Medicine, East Carolina University, Greenville, NC, United States.
Lynn A FussnerDivision of Pulmonary, Critical Care, and Sleep Medicine, Department of Internal Medicine, The Ohio State University, Columbus, OH, United States.
Michael YaegerDivision of Pulmonary, Critical Care, and Sleep Medicine, Department of Internal Medicine, The Ohio State University, Columbus, OH, United States.
Jim J AloorDiabetes and Obesity Institute, Department of Physiology, East Carolina University, Greenville, NC, United States.
Sky W ReeceDepartment of Pharmacology and Toxicology, Brody School of Medicine, East Carolina University, Greenville, NC, United States.
Brita J Kilburg-BasnyatDepartment of Pharmacology and Toxicology, Brody School of Medicine, East Carolina University, Greenville, NC, United States.
Sanjay VarikutiDivision of Pulmonary, Critical Care, and Sleep Medicine, Department of Internal Medicine, The Ohio State University, Columbus, OH, United States.
Bin LuoDepartment of Pharmacology and Toxicology, Brody School of Medicine, East Carolina University, Greenville, NC, United States.
Morgan InksDivision of Pulmonary, Critical Care, and Sleep Medicine, Department of Internal Medicine, The Ohio State University, Columbus, OH, United States.
Selin SerginDepartment of Food Science and Human Nutrition, Michigan State University, East Lansing, MI, United States.
Cameron A SchmidtDiabetes and Obesity Institute, Department of Physiology, East Carolina University, Greenville, NC, United States.
P Darrell NeuferDiabetes and Obesity Institute, Department of Physiology, East Carolina University, Greenville, NC, United States.
Edward Ross PenningtonDepartment of Nutrition, Gillings School of Global Public Health and School of Medicine, University of North Carolina, Chapel Hill, NC, United States.
Kelsey H Fisher-WellmanDiabetes and Obesity Institute, Department of Physiology, East Carolina University, Greenville, NC, United States.
Saiful M ChowdhuryDepartment of Chemistry and Biochemistry, University of Texas at Arlington, Arlington, TX, United States.
Michael B FesslerImmunity, Inflammation and Disease Laboratory, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, NC, United States.
Jenifer I FentonDepartment of Food Science and Human Nutrition, Michigan State University, East Lansing, MI, United States.
Ethan J AndersonDepartment of Pharmaceutical Sciences and Experimental Therapeutics, College of Pharmacy, FOE Diabetes Research Center, University of Iowa, Iowa City, IA, United States.
Saame Raza ShaikhDepartment of Nutrition, Gillings School of Global Public Health and School of Medicine, University of North Carolina, Chapel Hill, NC, United States.
Kymberly M GowdyDivision of Pulmonary, Critical Care, and Sleep Medicine, Department of Internal Medicine, The Ohio State University, Columbus, OH, United States. Electronic address: kymberly.gowdy@osumc.edu.
East Carolina University · USThe Ohio State University · USMichigan State University · USUniversity of North Carolina at Chapel Hill · USNational Institute of Environmental Health Sciences · USThe University of Texas at Arlington · USUniversity of Iowa · US

Funding

Cell Signaling of Host DefenseZIAES102005 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI FESSLER, MICHAEL B · 2009 to 2025
$41.7M
Dietary EPA mitigates ozone induced pulmonary inflammation through ChemR23 signalingR01ES031378 · NIEHS · OHIO STATE UNIVERSITY · PI Kymberly Mae Gowdy, SAAME R SHAIKH · 2020 to 2026
$3.7M
Cell Signaling of Host DefenseZ01ES102005 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI FESSLER, MICHAEL B · 2006 to 2008
$3.3M
Suppressing inflammation and boosting humoral immunity with n-3 PUFAsR01AT008375 · NCCIH · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SHAIKH, SAAME R · 2015 to 2019
$1.9M
Impact of organic cations on mitochondrial energetic driving forces and metabolic efficiencyR01DK110656 · NIDDK · EAST CAROLINA UNIVERSITY · PI NEUFER, P DARRELL · 2016 to 2019
$1.8M
Intramural NIH HHS Z01 ES102005NCCIH NIH HHS R01 AT008375NIDDK NIH HHS R01 DK110656NIEHS NIH HHS R01 ES031378
6 · The paper itself

Abstract

Prohibitins (PHB1 and PHB2) are ubiquitously expressed proteins which play critical roles in multiple biological processes, and together form the ring-like PHB complex found in phospholipid-rich cellular compartments including lipid rafts. Recent studies have implicated PHB1 as a mediator of fatty acid transport as well as a membrane scaffold mediating B lymphocyte and mast cell signal transduction. However, the specific role of PHBs in the macrophage have not been characterized, including their role in fatty acid uptake and lipid raft-mediated inflammatory signaling. We hypothesized that the PHB complex regulates macrophage inflammatory signaling through the formation of lipid rafts. To evaluate our hypothesis, RAW 264.7 macrophages were transduced with shRNA against PHB1, PHB2, or scrambled control (Scr), and then stimulated with lipopolysaccharide (LPS) or tumor necrosis factor-alpha (TNF-α), which activate lipid raft-dependent receptor signaling (CD14/TLR4 and TNFR1, respectively). PHB1 knockdown was lethal, whereas PHB2 knockdown (PHB2kd), which also resulted in decreased PHB1 expression, led to attenuated nuclear factor-kappa-B (NF-κB) activation and subsequent cytokine and chemokine production. PHB2kd macrophages also had decreased cell surface TNFR1, CD14, TLR4, and lipid raft marker ganglioside GM1 at baseline and post-stimuli. Post-LPS, PHB2kd macrophages did not increase the concentration of cellular saturated, monounsaturated, and polyunsaturated fatty acids. This was accompanied by decreased lipid raft formation and modified plasma membrane molecular packing, further supporting the PHB complex's importance in lipid raft formation. Taken together, these data suggest a critical role for PHBs in regulating macrophage inflammatory signaling via maintenance of fatty acid composition and lipid raft structure. SUMMARY: Prohibitins are proteins found in phospholipid-rich cellular compartments, including lipid rafts, that play important roles in signaling, transcription, and multiple other cell functions. Macrophages are key cells in the innate immune response and the presence of membrane lipid rafts is integral to signal transduction, but the role of prohibitins in macrophage lipid rafts and associated signaling is unknown. To address this question, prohibitin knockdown macrophages were generated and responses to lipopolysaccharide and tumor necrosis factor-alpha, which act through lipid raft-dependent receptors, were analyzed. Prohibitin knockdown macrophages had significantly decreased cytokine and chemokine production, transcription factor activation, receptor expression, lipid raft assembly and membrane packing, and altered fatty acid remodeling. These data indicate a novel role for prohibitins in macrophage inflammatory signaling through regulation of fatty acid composition and lipid raft formation.

Indexed as

ProhibitinsReceptors, Tumor Necrosis Factor, Type ICell MembraneChemokinesCytokinesFatty AcidsLipopolysaccharidesMacrophagesMembrane MicrodomainsPhospholipidsSignal TransductionToll-Like Receptor 4Tumor Necrosis Factor-alphaChemokinesCytokinesFatty AcidsLipopolysaccharidesPhospholipidsProhibitinsReceptors, Tumor Necrosis Factor, Type IToll-Like Receptor 4Tumor Necrosis Factor-alphaFatty acidInnate immunityLipid raftMacrophageProhibitinSignaling

Identifiers

PMID36706677
PMCPMC9992117
OpenAlexW4317470251

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.